Patent · US Active

Pyrrolidine aryl-ether as NK-3 receptor antagonists

US8012998B2 · kind B2 · utility

2Cited by

3References

8Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Philippe Jablonski · Steinbrunn-le-Haut, FR
Kenichi Kawasaki · Yokohama, JP
Henner Knust · Rheinfelden (Baden), DE
Anja Limberg · Penzberg, DE
Matthias Nettekoven · Weil am Rhein, DE
Hasane Ratni · Habsheim, FR
Claus Riemer · Glückstadt, DE
Xihan Wu · Shanghai, CN

Key dates

Filing date	Aug 4, 2008
Grant date	Sep 6, 2011
Priority date	—
Expiry date	Jan 20, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a compound of formula Iwherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.